ATLASATLAS fair value
ATLAS has no fair value for this stock today.
American Well (AMWL)
American Well stock price today, ATLAS forecast and fair value
Healthcare · Health Information Services · NYSE
$13.59▲ +0.37%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on American Well in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On American Well
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives American Well a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $12.06 and $14.99; in 9 out of 10, between $9.94 and $18.18. Estimated annual volatility is 59%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $207M
- 52-week high
- $14.56
- 52-week low
- $3.71
- Revenue (12 months)
- $219M
- Revenue growth (YoY)
- -2.0%
- Gross margin
- 53.3%
- Operating margin
- -42.2%
- Net margin
- -38.1%
- Return on equity
- -29.1%
- Free cash flow (12 months)
- $3.9M
- Beta
- 1.71
What this means
ATLAS does not publish a fair value for AMWL right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks AMWL has traded between $3.71 and $14.56. Today it is 6.7% below that high and 266% above its low.
On the business: revenue fell 2.0% year over year; net margin is 38.1%.
Its beta is 1.71: it tends to move more than the market, both up and down.
About the company
American Well Corporation Class A Common Stock represents ownership in American Well Corporation, a digital healthcare company focused on telehealth and hybrid care delivery.
Want to see everything about American Well?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does American Well do?
American Well Corporation Class A Common Stock represents ownership in American Well Corporation, a digital healthcare company focused on telehealth and hybrid care delivery.
What is the chance AMWL goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, AMWL ends the month between $12.06 and $14.99.
How big is American Well and what is its P/E ratio?
American Well's market capitalization is $207M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is AMWL?
ATLAS estimates annual volatility at 59%. In a typical month, half of the outcomes end between $12.06 and $14.99.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer